Bakkt Advances Indian Investment Following Regulatory Approval
Bakkt announced it received required Indian regulatory approvals for its strategic warrant investment in Transchem Limited (BSE: 500422).
Bakkt announced it received required Indian regulatory approvals for its strategic warrant investment in Transchem Limited (BSE: 500422).
Source: Bakkt